Skip to main content
. 2013 Jun 6;2013(6):CD009620. doi: 10.1002/14651858.CD009620.pub2

Kosmidis 1997.

Methods Not specified
Participants 83 women with median age 56 years. 74% had stage III while 435 had serious and 25% had mucinous adenocarcinoma. 30% had an optimal operation with residual disease and treated with chemotherapy. Of the 86 women 44 had complete clinical remission (cCR) and they were randomised to receive either interferon‐alpha 2b or observation alone
Interventions Intervention:
Intraperitoneal interferon was given
Control:
Patients were observed
Outcomes
  • Overall survival

  • Feasibility of interferon

  • Tolerance of interferon

Notes The full text article has been requested from authors but we have not received any response.